Search results
BLUE INVESTOR NEWS: TOP RANKED ROSEN LAW FIRM Encourages bluebird bio Inc. Investors to Secure...
The Sun Chronicle· 6 days agoWHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of bluebird bio, Inc. (NASDAQ: BLUE) between April 24, 2023 and December 8, 2023 ...
FDA grants breakthrough status to Soleno's PWS drug By Investing.com
Investing.com· 4 days agoTherapeutics, Inc. (NASDAQ: NASDAQ:SLNO) has received Breakthrough Therapy Designation from the U.S....
The Zacks Analyst Blog Highlights Gilead Sciences, GSK, Deciphera, Bristol Myers and Editas Medicine
Zacks via Yahoo Finance· 2 hours agoThe significant premium offered impressed investors. The acquisition is expected to close in the...
BLUE Investors Have Opportunity to Lead bluebird bio, Inc. Securities Fraud Lawsuit
KAMR Amarillo· 4 days ago("bluebird" or the "Company") (NASDAQ: BLUE). The complaint filed alleges that, throughout the Class Period, Defendants misled investors by creating the false impression that ...
Sotera Health (SHC) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 9 hours agoPlease recognize that we are in active litigation, we will not...permanent total closure technology and other state-of-the-art emission controls have...
Q1 2024 Geron Corp Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 8 hours agoThis offering included participation from RA Capital, Fairmont Bourbon that Farrell on adage Boxer, Vivo, deep track and multiple large investment management firms in addition to other new and ...
Moderna Breaks Out For The First Time In A Year After Covid Shot Wallops Sales Views
Investor's Business Daily· 15 hours agoBut it can be serious or deadly in babies and older adults. The FDA is due to make its decision on...
Investors trying to take control of Norfolk Southern railroad pick up key support
Quartz· 4 days agoThe activist investors trying to take control of Norfolk Southern's board are picking up key...
FDA approves first targeted therapy for WHIM syndrome By Investing.com
Investing.com· 4 days agoX4 Pharmaceuticals (NASDAQ:XFOR) announced today the U.S. Food and Drug Administration (FDA) has...
BLUE Investors Have Opportunity to Lead bluebird bio, Inc. Securities Fraud Lawsuit
WTNH-TV New Haven· 19 hours agoLOS ANGELES, May 2, 2024 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") announces that ...
